What is Nabla Bio?
Nabla Bio is a biotechnology company that develops integrated AI and experimental technologies to design antibodies. By combining generative AI models with massively parallel experimentation, the company aims to address challenging disease targets, such as GPCRs and ion channels.
Nabla Bio believes in the close integration of AI-guided design and wet-lab driven measurement. This approach is intended to enable the development of drugs with superior manufacturability, safety, and efficacy for diseases that are currently difficult to treat.
Features
- Generative Models: Utilizes AI to design novel antibodies.
- Multiplexed Screens: Employs high-throughput experimental methods.
- Protein Characterization: Technologies for detailed analysis of proteins.
- De Novo Antibody Design: Creates antibodies from scratch using AI.
- Wet-Lab Integration: Combines AI design with experimental validation.
Use Cases
- Developing drugs for diseases that elude current treatments.
- Designing antibodies against challenging targets like GPCRs and ion channels.
- Improving drug manufacturability.
- Enhancing drug safety profiles.
- Increasing drug efficacy.
